Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SARS and Avian Flu -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (78)	4/11/2003 11:20:58 AM
From: Biomaven	Read Replies (2) \| Respond to of 4232

mixed sentiments Agreed. There is some (small?) chance that their stuff might help, but let them wait for a PR until they have some evidence that it does. It's not yet clear whether the major lung damage is from the virus itself or from the immune system's attempts to deal with the virus. The fact that steroids seem to help hints that the latter might be part of the problem. If so, immune stimulants might be a double-edged sword. (Just thinking out loud here from a pretty uninformed position). More articles today saying that ribavirin doesn't work, based purely on the in vitro tests. But as I said previously, ribavirin has lots of effects on the immune system, so the fact that it doesn't work in vitro doesn't mean it won't help in people. Peter